U.S. stocks on the move: Nvidia, Medline, CG Oncology
NVDA•U.S. stocks were set to open lower on Monday as AI-related shares faced pressure ahead of Nvidia's earnings later in the week. Medline slipped as sponsors looked to reduce their stake in a secondary offering, while CG Oncology gained after trial data showed reduced tumor recurrence risk.
1. Market and AI shares
The S&P 500 and Nasdaq were on track to open lower on Monday as AI-related companies faced fresh pressure before Nvidia's earnings later in the week. The article cited continuing market fallout from Jensen Huang's resignation. Marvell Technology, Applied Materials, Intel and Western Digital were among AI-linked stocks falling further, while server makers Dell Technologies, Super Micro Computer and Hewlett Packard Enterprise extended losses.
2. Company moves
Medline shares slipped as sponsors looked to cut their stake in a secondary offering. CG Oncology shares gained after a trial showed its drug reduced the risk of tumor recurrence. Other moves included Summit Therapeutics falling after the FDA declined approval of its lung cancer drug, Tyson Foods falling after forecasting a steeper-than-expected annual revenue decline, and Insight Enterprises slipping after unveiling a $650 million convertible bond offering.




